Locating the right evidence for merger decisions

Candace Imison asks whether potentially merging trusts’ evidence will meet the Competition and Cooperation panel’s exacting review standards, and what the challenge means for the 20 currently unviable trusts in the FT status pipeline.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here